DexCom (DXCM)
(Delayed Data from NSDQ)
$124.34 USD
-13.67 (-9.91%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $124.32 -0.02 (-0.02%) 5:40 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Price, Consensus and EPS Surprise
DXCM 124.34 -13.67(-9.91%)
Will DXCM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DXCM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DXCM
DexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues
DexCom (DXCM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
DXCM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Bulls Look Optimistic About DexCom (DXCM): Should You Buy?
DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Other News for DXCM
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?
What You Missed On Wall Street This Morning
DexCom price target raised by $9 at Raymond James, here's why
Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Gilead Sciences (GILD)
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket